These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8913986)

  • 1. Estrogen replacement. The evolving role of transdermal delivery.
    Lobo RA; Ettinger B; Hutchinson KA; Knopp RH; Lindsay R; Nachtigall LE; Santoro N; Studd J
    J Reprod Med; 1996 Oct; 41(10 Suppl):781-96. PubMed ID: 8913986
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 4. Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?
    Clarkson TB; Karas RH
    Menopause; 2007; 14(6):963-7. PubMed ID: 17909452
    [No Abstract]   [Full Text] [Related]  

  • 5. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
    Kanis JA
    Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
    [No Abstract]   [Full Text] [Related]  

  • 6. Transdermal estrogen and prevention of osteoporosis.
    Filer WD; Filer RB
    Am Fam Physician; 1994 May; 49(7):1639-44. PubMed ID: 8184798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women].
    Zhang YW
    Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):487-8. PubMed ID: 14627037
    [No Abstract]   [Full Text] [Related]  

  • 11. HRT dosing regimens: continuous versus cyclic-pros and cons.
    Shoupe D
    Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of oral versus non-oral hormonal treatments in menopause].
    Sitruk-Ware R
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):688-93. PubMed ID: 8991902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The resistable rise of transdermal prevention].
    Berrino F
    Epidemiol Prev; 1997; 21(2):87-8. PubMed ID: 9378187
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of osteoporosis using estrogen and gestagens].
    Lauritzen C
    Gynakologe; 1992 Feb; 25(1):31-5. PubMed ID: 1547979
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
    Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
    Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCPL delivery system as a model for E + P replacement therapy in post-ovariectomized adult rats mimicking a postmenopausal condition.
    Cason Z; Benghuzzi H; Tucci M; England B
    Biomed Sci Instrum; 2003; 39():529-34. PubMed ID: 12724947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.